Stock AMGN AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Amgen Inc.

Equities

AMGN

US0311621009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
310.2 USD -0.87% Intraday chart for Amgen Inc. -0.37% +7.68%
May. 09 ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive... Our Logo
May. 09 Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170 MT

Chart calendar Amgen Inc.

d8ad74188d.iZHMljYDIasmAP6Um2IMZyfI6gdMLnpOSteDfiSfD8M._8Co2Vw7ec9rSIj90TA8XkutpXUafwwCLo_pKV7uPrH6457lZ2ZXxXVwuw~6b3bb2f7d3a78aaa7df9e84f8aeaf002

Upcoming events on Amgen Inc.

2024-05-14 09:20 am Bank of America Merrill Lynch Global Healthcare Conference
2024-05-19 12:15 pm American Thoracic Society Conference - Efficacy and Safety of Avacopan Versus
2024-05-19 05:15 pm American Thoracic Society Conference - Phase 1 Safety and Efficacy of AZD8630/AMG104
2024-05-19 05:15 pm American Thoracic Society Conference - Greater Exacerbation Reductions with Earlier Biologic Initiat
2024-05-19 05:15 pm American Thoracic Society Conference - Session No. A101
2024-05-20 12:15 pm American Thoracic Society Conference
2024-05-20 12:50 pm American Thoracic Society Conference - Session No. B13
2024-05-21 02:30 pm American Thoracic Society Conference - Patient Characteristics and Treatment Patterns
2024-05-21 02:30 pm American Thoracic Society Conference - Effect of Tezepelumab on Exercise Tolerance
2024-05-21 02:30 pm American Thoracic Society Conference - Efficacy of Tezepelumab in Black or African American Patients
2024-05-21 02:30 pm American Thoracic Society Conference - Efficacy of Biologics for Reducing
2024-05-21 02:30 pm American Thoracic Society Conference - Effect of Biologics on Biomarkers
2024-05-21 02:30 pm American Thoracic Society Conference - Poster Session No. C34
2024-05-21 02:30 pm American Thoracic Society Conference - Poster Session No. C31
2024-05-21 05:15 pm American Thoracic Society Conference - Reduced Mucus Plugging with Tezepelumab

Past events on Amgen Inc.

2024-05-02 04:30 pm Q1 2024 Earnings Call
2024-05-02 04:01 pm Q1 2024 Earnings Release
2024-03-09 07:50 pm American Academy of Dermatology Meeting
2024-03-09 07:15 pm American Academy of Dermatology Meeting - Abstracts No - #51067
2024-03-09 06:55 pm American Academy of Dermatology Meeting - Abstracts No - #50668
2024-03-09 12:20 pm American Academy of Dermatology Meeting
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #50233
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #52846
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #51480
2024-03-07 American Academy of Dermatology Meeting - Abstracts No - #51246
2024-03-05 09:10 am TD Cowen Health Care Conference
2024-02-22 04:00 pm Business Update Call
2024-02-14 Ex-dividend day
2024-02-14 12:00 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-06 04:30 pm Q4 2023 Earnings Call
2024-02-06 04:01 pm Q4 2023 Earnings Release
2024-01-08 12:00 pm JPMorgan Healthcare Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No: 4092
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract #4092
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No: 4705

Past dividends on Amgen Inc.

2024-02-14 Quarterly 2.25 USD
2023-11-15 Quarterly 2.13 USD
2023-08-16 Quarterly 2.13 USD
2023-05-16 Quarterly 2.13 USD
2023-02-13 Quarterly 2.13 USD
2022-11-15 Quarterly 1.94 USD
2022-08-16 Quarterly 1.94 USD
2022-05-15 Quarterly 1.94 USD
2022-02-13 Quarterly 1.94 USD
2021-11-14 Quarterly 1.76 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		23 362
23 196
0.71%		25 424
25 363
0.24%		25 979
25 999
-0.08%		26 323
26 247
0.29%		28 190
28 108
0.29%
33 024

EBITDA
Million USD		Released
Forecast
Spread 		13 363
13 029
2.56%		15 935
15 167
5.06%		15 822
16 002
-1.12%		16 178
15 935
1.53%		17 470
16 351
6.84%
19 420

EBIT
Million USD		Released
Forecast
Spread 		11 157
11 138
0.17%		12 334
12 315
0.15%		12 424
12 479
-0.44%		12 761
12 728
0.26%		13 399
13 423
-0.18%
14 846

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		9 138
9 499
-3.8%		8 133
8 782
-7.39%		6 701
6 379
5.04%		7 346
7 466
-1.6%		7 855
8 859
-11.33%
4 809

Net income
Million USD		Released
Forecast
Spread 		7 842
7 850
-0.1%		7 264
7 163
1.41%		5 893
5 598
5.27%		6 552
6 525
0.41%		6 717
7 401
-9.24%
4 175

EPS
USD		Released
Forecast
Spread 		12,9
12,8
0.4%		12,3
12,0
2.4%		10,3
9,84
4.5%		12,1
12,1
0.41%		12,5
13,8
-9.66%
7,81

Announcement Date30/01/2002/02/2107/02/2231/01/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		6 238
6 111
2.08%		6 594
6 526
1.04%		6 652
6 556
1.47%		6 839
6 766
1.08%		6 105
6 177
-1.17%		6 986
6 680
4.58%		6 903
6 948
-0.65%		8 196
8 106
1.11%		7 447
7 453
-0.08%
8 316


8 434


8 804


8 099


8 592

EBITDA
Million USD		Released
Forecast
Spread 		3 981
3 747
6.24%		4 163
3 953
5.31%		4 114
4 068
1.13%		3 920
3 744
4.7%		3 721
3 684
1.01%		4 411
4 152
6.25%		4 298
4 443
-3.25%		5 040
4 568
10.32%		4 477
4 373
2.37%
5 147


5 302


5 053







EBIT
Million USD		Released
Forecast
Spread 		3 140
2 939
6.84%		3 335
3 152
5.8%		3 277
3 201
2.39%		3 009
2 976
1.11%		2 821
2 879
-2.01%		3 515
3 292
6.77%		3 403
3 424
-0.62%		3 660
3 689
-0.78%		3 078
3 164
-2.71%
3 796


3 914


4 023


3 588


3 975

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 675
2 243
-25.32%		1 531
2 046
-25.18%		2 392
2 021
18.36%		1 748
1 866
-6.32%		3 442
2 294
50.04%		1 614
2 402
-32.81%		1 947
2 183
-10.81%		852
1 517
-43.85%		-68,0
1 214
-105.6%
1 719


1 749


1 410


2 599


2 985

Net income
Million USD		Released
Forecast
Spread 		1 476
1 725
-14.42%		1 317
1 749
-24.72%		2 143
1 665
28.68%		1 616
1 686
-4.16%		2 841
1 479
92.11%		1 379
1 840
-25.04%		1 730
1 772
-2.38%		767
1 308
-41.36%		-113
1 127
-110.03%
1 267


1 413


1 209


1 663


1 996

EPS
USD		Released
Forecast
Spread 		2,68
3,24
-17.27%		2,45
3,28
-25.3%		3,98
3,06
30.15%		3,00
3,21
-6.6%		5,28
2,98
77.12%		2,57
3,40
-24.34%		3,22
3,29
-2.1%		1,42
2,36
-39.72%		-0,21
2,71
-107.75%
2,53


2,82


2,45


3,11


3,74

Announcement Date27/04/2204/08/2203/11/2231/01/2327/04/2303/08/2331/10/2306/02/2402/05/24-----

Upcoming sector events for Amgen Inc.

2024-05-12 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
2024-05-12 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
2024-05-12 ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release
2024-05-12 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-12 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MEGA LIFESCIENCES: Q1 2024 Earnings Release
2024-05-12 ALMIRALL, S.A.: Q1 2024 Earnings Release
2024-05-12 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-12 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Amgen Inc.

2024-05-10 11:01 am PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-10 06:50 am ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-10 06:46 am NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-09 NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
2024-05-09 KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-09 JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-05-09 TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
2024-05-09 04:02 pm COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
2024-05-09 09:58 am SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release
2024-05-09 09:06 am ABBOTT INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. Calendar Amgen Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW